Results 191 to 200 of about 511,877 (268)
Interaction and biological pathway analysis of proteomic products in patients with premature coronary artery disease. [PDF]
Cai L +11 more
europepmc +1 more source
ABSTRACT Background Intravascular lithotripsy (IVL) fractures calcified plaques and facilitates lesion expansion; however, unlike atherectomy devices, it does not reduce calcium volume. The therapeutic efficacy and safety of combining IVL with atherectomy remain unclear. Therefore, this study aimed to evaluate, through optical coherence tomography (OCT)
Marohito Nakata +3 more
wiley +1 more source
Left Main Disease: The Last Frontier for Medical Therapy in Stable Coronary Artery Disease? [PDF]
Arbab-Zadeh A +5 more
europepmc +1 more source
ABSTRACT With recent advances in endovascular therapy (EVT), treatment of complex peripheral artery disease, especially below‐the‐knee lesions, has become increasingly feasible using intravascular ultrasound (IVUS)‐guided techniques. However, reports on EVT for critical digital ischemia remain scarce because of its rarity.
Yasuyuki Tsuchida +6 more
wiley +1 more source
The association of coronary artery disease by coronary CT angiography & cardiovascular outcomes in Psoriatic disease. [PDF]
Aun JA +19 more
europepmc +1 more source
Applying DanGer Shock Eligibility Criteria to a Real‐World Cohort of Cardiogenic Shock Patients
ABSTRACT Background The DanGer Shock trial investigated the effects of adding a microaxial flow pump to guideline‐recommended therapy in patients with ST‐elevation myocardial infarction (STEMI)‐related cardiogenic shock (CS), finding a lower all‐cause mortality at 180 days in the intervention group.
Raffaela Miriam Planka +14 more
wiley +1 more source
Comparison of coronary artery disease involvement in patients with or without familial history. [PDF]
Khameneh Bagheri R +6 more
europepmc +1 more source
The Prognostic Value of Troponin in Acute Pulmonary Embolism: A Systematic Review and Meta‐Analysis
ABSTRACT Acute pulmonary embolism (PE) is a major cause of cardiovascular morbidity and mortality. Troponin elevation is increasingly used for risk stratification, but its prognostic utility remains variably reported across studies. To evaluate the prognostic value of troponin elevation in patients with acute PE, concerning short‐term mortality and ...
Ahmed T. Elmewafy +4 more
wiley +1 more source

